Schrodinger, Inc.
Long
Updated

SDGR Potential Buying Opportunity Here

Good News for SDGR
"Schrodinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting"

Premarket : Testing the resistance

Once it clear 27 $, 10% upside potential .

Note
Here we go!!
snapshot

Disclaimer